Asset Management One’s Ascendis Pharma A/S ASND Stock Holding History

Asset Management One’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Hold	3,805	–	–	﹤0.01%	752
2026 Q1	$870K	Buy	+3,805	New	+$853K	﹤0.01%	752
2022 Q3	–	Sell	-100	Closed	-$9K	–	1010
2022 Q2	$9K	Hold	100	–	–	﹤0.01%	1016
2022 Q1	$11K	Hold	100	–	–	﹤0.01%	1030
2021 Q4	$13K	Hold	100	–	–	﹤0.01%	1040
2021 Q3	$15K	Hold	100	–	–	﹤0.01%	1034
2021 Q2	$13K	Buy	+100	New	+$13.3K	﹤0.01%	1040

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Asset Management One's ASND Position: Q2 2026 in Review

Asset Management One held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 3,805 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #752.

Asset Management One first reported a position in ASND in Q2 2021 and has held it in 7 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Asset Management One held 3,805 shares of Ascendis Pharma A/S worth $1.01M as of Q2 2026.
Asset Management One left its Ascendis Pharma A/S share count unchanged in Q2 2026.
Ascendis Pharma A/S made up ﹤0.01% of Asset Management One's portfolio in Q2 2026, its #752 holding.
Asset Management One first reported a position in Ascendis Pharma A/S in Q2 2021 and has held it in 7 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.